Chris Towler

Chris Towler is an experienced professional in pharmaceutical development with a robust academic background, including a PhD and MSc from the University of Manchester - Institute of Science and Technology. Towler's career includes roles at various institutions, such as Purdue University and UMIST, focusing on postdoctoral research in organic salts and nanoparticle crystallization. At Novartis, Towler has held multiple leadership roles, including Associate Director and Principal Scientist, where responsibilities encompassed drug substance development for Phase I studies, preclinical project evaluation, and formulation development for various compounds. Currently, Towler serves as Director at Merck, overseeing a team dedicated to the assessment of compound developability across multiple disease areas.